Adenotonsillectomy is associated with increased risk and disease activity in pediatric-onset multiple sclerosis

Gina Chang1, Zahra Nasr1, Vinicius Andreoli Schoeps2

  • 1UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|May 29, 2026
PubMed

Insights

A history of adenotonsillectomy was linked to a higher risk of developing pediatric-onset multiple sclerosis (MS). This procedure also correlated with an increased relapse rate in children already diagnosed with MS.

Area of Science:

  • Neurology
  • Immunology
  • Virology

Background:

  • Epstein-Barr virus (EBV) is a known risk factor for multiple sclerosis (MS).
  • Tonsils and adenoids are identified as primary reservoirs for EBV.
  • The study explores the impact of adenotonsillectomy on pediatric MS risk and disease activity.

Purpose of the Study:

  • To investigate the association between adenotonsillectomy and the risk of pediatric-onset multiple sclerosis (POMS).
  • To evaluate the effect of adenotonsillectomy on the relapse rate in pediatric MS patients.

Main Methods:

  • A case-control study involving POMS participants and pediatric controls.
  • Data collection included history of adenotonsillectomy, EBV serostatus, and HLA status.
  • Statistical analyses utilized multivariable logistic and negative binomial regression models.

Main Results:

  • Adenotonsillectomy was associated with a 63% increased odds of developing MS (OR=1.63, p=0.046).
  • Among POMS patients, adenotonsillectomy correlated with a twofold increase in annualized relapse rate (IRR=2.00, p=0.013).

Conclusions:

  • Prior adenotonsillectomy is linked to elevated MS risk and higher relapse rates in pediatric patients.
  • Findings suggest a potential interaction between EBV, immune responses, and MS development.
Abstract

Related Concept Videos